Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Risk assessment for neurotoxic effects.

D W Gaylor¹, W Slikker

¹National Center for Toxicological Research, Jefferson, Arkansas 72079.

Neurotoxicology

|January 11, 1990

Summary

This study introduces a novel method for estimating neurotoxicant risk using bioassay data. It defines risk as the proportion of a population exceeding abnormal toxicity levels, offering a more versatile approach than traditional methods.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Discontinuation of methylphenidate after long-term exposure in nonhuman primates.

Neurotoxicology and teratology·2023

Same author

MicroPET/CT assessment of neurochemical effects in the brain after long-term methylphenidate treatment in nonhuman primates.

Neurotoxicology and teratology·2021

Same author

Programming microphysiological systems for children's health protection.

Experimental biology and medicine (Maywood, N.J.)·2017

Same author

Minimally invasive biomarkers of general anesthetic-induced developmental neurotoxicity.

Neurotoxicology and teratology·2016

Same author

MicroPET/CT assessment of FDG uptake in brain after long-term methylphenidate treatment in nonhuman primates.

Neurotoxicology and teratology·2016

Same author

Clinical outcomes of proximal row carpectomy versus four-corner arthrodesis for post-traumatic wrist arthropathy: a systematic review.

The Journal of hand surgery, European volume·2014

Area of Science:

Toxicology
Risk Assessment
Neuroscience

Background:

Current neurotoxicant regulation relies on the no observed adverse effect level (NOAEL) and uncertainty factors.
This traditional approach does not quantify risk as a function of dose or acknowledge risk at the NOAEL.

Purpose of the Study:

To demonstrate a method for estimating neurotoxic effects risk using bioassay data.
To propose an alternative to the NOAEL/uncertainty factor approach for risk assessment.

Main Methods:

Utilizing biomarkers as measures of toxicity when direct neurotoxic effects are unmeasurable.
Establishing abnormal toxicity levels based on a small, unexposed population fraction.
Defining risk as the population proportion exceeding abnormal toxicity levels.

Main Results:

The method was illustrated using neurochemical, neurohistological, and behavioral data from methylenedioxymethamphetamine (MDMA) exposure in rats and monkeys.
This bioassay-driven risk estimation provides dose-dependent risk insights.

Conclusions:

The proposed method offers a more versatile approach to risk assessment for potential neurotoxic substances.
It provides quantitative risk estimates across a range of doses, unlike the NOAEL approach.

Related Experiment Videos